Formulation and Drug Delivery, Specialty Dosage Forms

Advances in Delivering Protein and Peptide Therapeutics

November 02, 2016

A variety of strategies have been employed to deliver proteins and peptides in improved parenteral formulations and/or via noninvasive routes.

Tapemark Showcases Transdermal, Oral Thin Film, and Topical Drug-Delivery Systems at CPhI

September 30, 2016

Tapemark, a full-service CDMO specializing in transdermal, oral thin film, and topical drug-delivery technologies, is exhibiting at CPhI.

West Features Injectable Packaging and Drug-Delivery Innovations at CPhI 2016

September 22, 2016

West will showcase several drug-delivery systems and packaging component technologies such as its NovaPure plungers and SmartDose technology platform.

Contact Lenses as a Potential Drug Delivery Method for Glaucoma

August 30, 2016

Researchers at the Massachusetts Eye and Ear Infirmary developed a potential drug delivery method using a contact lens to deliver glaucoma medication.

FDA Releases Guidance on Topical Patches

May 31, 2016

The agency publishes draft guidance on assessing the adhesion of transdermal delivery systems and topical patches.

Optimizing Semisolid Dosage Forms

December 02, 2015

Quality by design, in-vitro release testing, and modern analytical methods are improving understanding and control of these complex formulations.

Dow Corning Showcases Scar and Stretchmark Solutions

October 07, 2015

Dow Corning will also be presenting topical and transdermal technology advances at CPhI.

Impel and 3M Partner to Advance Olfactory Drug Delivery

October 06, 2015

3M and Impel will collaborate to develop and commercialize Impel’s Precision Olfactory Delivery technology for enhanced central nervous system drug delivery.

Transdermal Drug Delivery Gains Traction

May 04, 2015

Advances in transdermal drug delivery, particularly with microneedles, are enabling a wider range of drugs to be delivered through the skin.

Contact Lens For Prolonged Delivery of Glaucoma Medication

December 11, 2013

Researchers at Massachusetts recently reported on the development of a drug-eluting contact lens designed to provide prolonged delivery of the glaucoma medication, latanoprost.